41 results
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
product candidates and our business could be substantially harmed. Disruptions in our supply chain could delay the commercial launch of our product … supply chain capacity sufficient to provide commercial quantities of any product candidates for which we may obtain regulatory approval; seek regulatory
8-K
EX-99.1
XFOR
X4 Pharmaceuticals Inc
18 Oct 23
X4 Pharmaceuticals Announces Appointment of Industry Veteran R. Keith Woods to Board of Directors
8:17am
, international operations, supply chain, and business strategy, as well as his recent successful global launch of a rare disease product, we believe it is a great … than 30 years of life science experience spanning sales, global operations, supply chain, business strategy, and commercialization to the X4 Board
8-K
EX-99.3
7yk2x7r1
16 May 23
X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market
4:24pm